Cassava Sciences Inc Financial Statements (SAVA)
|
|
|
|
Report date
|
|
|
07.11.2023 |
28.02.2024 |
10.05.2024 |
08.08.2024 |
07.11.2024 |
|
07.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
0.000 |
2.35 |
0.000 |
0.000 |
0.000 |
|
2.35 |
|
Operating Income, bln rub |
|
|
-27.9 |
-22.8 |
-19.9 |
-67.2 |
-30.6 |
|
-140.5 |
|
EBITDA, bln rub |
? |
|
-27.5 |
-22.4 |
-19.6 |
-61.1 |
-30.4 |
|
-133.5 |
|
Net profit, bln rub |
? |
|
-25.7 |
-20.9 |
25.0 |
6.16 |
-27.9 |
|
-17.7 |
|
|
OCF, bln rub |
? |
|
-26.5 |
-22.3 |
-19.1 |
-18.2 |
-18.3 |
|
-78.0 |
|
CAPEX, bln rub |
? |
|
0.022 |
0.041 |
0.000 |
0.029 |
0.017 |
|
0.087 |
|
FCF, bln rub |
? |
|
-26.6 |
-22.4 |
-19.1 |
-18.3 |
-18.3 |
|
-78.1 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
27.9 |
22.4 |
19.6 |
66.9 |
30.6 |
|
139.6 |
|
Cost of production, bln rub |
|
|
0.392 |
0.356 |
0.311 |
0.300 |
0.000 |
|
0.967 |
|
R&D, bln rub |
|
|
23.6 |
18.7 |
16.2 |
15.2 |
17.7 |
|
67.8 |
|
Interest expenses, bln rub |
|
|
0.000 |
2.63 |
0.000 |
0.000 |
0.000 |
|
2.63 |
|
|
Assets, bln rub |
|
|
172.5 |
151.7 |
155.7 |
243.6 |
223.8 |
|
223.8 |
|
Net Assets, bln rub |
? |
|
155.1 |
137.5 |
78.6 |
189.0 |
166.6 |
|
166.6 |
|
Debt, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Cash, bln rub |
|
|
142.4 |
121.1 |
124.2 |
207.3 |
149.0 |
|
149.0 |
|
Net debt, bln rub |
|
|
-142.4 |
-121.1 |
-124.2 |
-207.3 |
-149.0 |
|
-149.0 |
|
|
Ordinary share price, rub |
|
|
16.6 |
22.5 |
20.3 |
12.4 |
29.4 |
|
25.8 |
|
Number of ordinary shares, mln |
|
|
42.0 |
42.2 |
43.0 |
46.2 |
48.0 |
|
48.0 |
|
|
Market cap, bln rub |
|
|
699 |
950 |
872 |
571 |
1 412 |
|
1 235 |
|
EV, bln rub |
? |
|
557 |
829 |
748 |
363 |
1 263 |
|
1 086 |
|
Book value, bln rub |
|
|
155 |
137 |
78 |
189 |
167 |
|
167 |
|
|
EPS, rub |
? |
|
-0.61 |
-0.50 |
0.58 |
0.13 |
-0.58 |
|
-0.37 |
|
FCF/share, rub |
|
|
-0.63 |
-0.53 |
-0.44 |
-0.40 |
-0.38 |
|
-1.63 |
|
BV/share, rub |
|
|
3.69 |
3.25 |
1.83 |
4.09 |
3.47 |
|
3.47 |
|
|
EBITDA margin, % |
? |
|
|
-955.4% |
|
|
|
|
-5 686% |
|
Net margin, % |
? |
|
|
-890.9% |
|
|
|
|
-752.3% |
|
FCF yield, % |
? |
|
-11.6% |
-8.68% |
-10.1% |
-15.1% |
-5.53% |
|
-6.32% |
|
ROE, % |
? |
|
-58.7% |
-68.8% |
-60.9% |
-8.13% |
-10.6% |
|
-10.6% |
|
ROA, % |
? |
|
-52.7% |
-62.4% |
-30.8% |
-6.31% |
-7.89% |
|
-7.89% |
|
|
P/E |
? |
|
-7.68 |
-10.0 |
-18.2 |
-37.1 |
-79.9 |
|
-69.9 |
|
P/FCF |
|
|
-8.62 |
-11.5 |
-9.92 |
-6.61 |
-18.1 |
|
-15.8 |
|
P/S |
? |
|
0.00 |
404.5 |
371.6 |
243.0 |
601.3 |
|
526.1 |
|
P/BV |
? |
|
4.51 |
6.92 |
11.1 |
3.02 |
8.48 |
|
7.42 |
|
EV/EBITDA |
? |
|
-5.37 |
-7.87 |
-7.61 |
-2.78 |
-9.46 |
|
-8.14 |
|
Debt/EBITDA |
|
|
1.37 |
1.15 |
1.26 |
1.59 |
1.12 |
|
1.12 |
|
|
R&D/CAPEX, % |
|
|
107 286% |
45 685% |
|
52 407% |
103 976% |
|
77 975% |
|
|
CAPEX/Revenue, % |
|
|
|
1.75% |
|
|
|
|
3.71% |
|
| Cassava Sciences Inc shareholders |
